Halsa Pharmaceutical- ZAG Presentation
Zinc-alpha-2-glycoprotein (ZAG) is a novel, safe, and highly effective treatment for obesity and type II diabetes. Its potential health benefits are enormous. ZAG will improve the treatment of the chronic diseases arising from the metabolic syndrome that are well known to be bankrupting the American health care system. However, it may also reshape the modern medical landscape through its ability to improve or even prevent the multiple cellular changes that lead to these conditions years before they manifest as disease.